Groen J W, Negenborn V L, Twisk D J W R, Rizopoulos D, Ket J C F, Smit J M, Mullender M G
Department of Plastic Surgery and Biostatistics, VU Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Department of Plastic Surgery and Biostatistics, VU Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands; EMGO Institute for Health and Care Research, Van der Boechorststraat 7, 1081 Amsterdam, The Netherlands.
J Plast Reconstr Aesthet Surg. 2016 Jun;69(6):742-764. doi: 10.1016/j.bjps.2016.03.019. Epub 2016 Mar 29.
This study presents an up-to-date overview of the literature on autologous fat grafting (AFG) in onco-plastic breast reconstruction, with respect to complications, oncological and radiological safety, volume retention and patient/surgeon satisfaction.
Although AFG is increasingly being applied in onco-plastic breast reconstruction, a comprehensive overview of the available evidence for this procedure is still lacking.
A systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement was conducted. Case series, cohort studies and randomized controlled trials (RCTs) reporting on relevant outcomes of breast reconstruction with supplemental AFG were included.
In total, 43 studies were included reporting on 6260 patients with a follow-up period ranging from 12 to 136 months. The average locoregional and distant oncological recurrence rates after breast reconstruction with AFG were 2.5% (95% confidence interval (CI) 1.7-3.7) and 2.0% (95% CI 1.1-3.5), respectively. Fewer cysts and calcifications were seen on radiological images for this procedure than for other types of breast surgery. However, more biopsies were performed based on radiological findings (3.7% vs. 1.6%), and more cases of fat necrosis (9.0% vs 4.7%) were seen after treatment with AFG. The total complication rate of 8.4% (95% CI 7.6-9.1) is lower than those reported following other reconstructive breast procedures. The mean volume retention was 76.8% (range 44.7-82.6%) with a satisfaction rate of 93.4% for patients and 90.1% for surgeons.
AFG in breast reconstruction is a promising technique. Safety is not compromised as cancer recurrence and complications are not observed. Whether AFG interferes with radiological follow-up remains to be elucidated. Randomized trials with sound methodology are needed to confirm these conclusions.
本研究对肿瘤整形乳房重建中自体脂肪移植(AFG)的相关文献进行了最新综述,内容涉及并发症、肿瘤学和放射学安全性、体积保留情况以及患者/外科医生满意度。
尽管AFG在肿瘤整形乳房重建中的应用越来越广泛,但对于该手术现有证据的全面综述仍较为缺乏。
按照系统评价和Meta分析的首选报告项目(PRISMA)声明进行了系统评价。纳入了报告补充AFG乳房重建相关结果的病例系列、队列研究和随机对照试验(RCT)。
共纳入43项研究,涉及6260例患者,随访期为12至136个月。采用AFG进行乳房重建后的平均局部区域和远处肿瘤复发率分别为2.5%(95%置信区间(CI)1.7 - 3.7)和2.0%(95%CI 1.1 - 3.5)。与其他类型的乳房手术相比,该手术在放射影像上出现的囊肿和钙化较少。然而,基于放射学检查结果进行的活检更多(3.7%对1.6%),且AFG治疗后脂肪坏死病例更多(9.0%对4.7%)。8.4%(95%CI 7.6 - 9.1)的总并发症发生率低于其他乳房重建手术报告的发生率。平均体积保留率为76.8%(范围44.7 - 82.6%),患者满意度为93.4%,外科医生满意度为90.1%。
乳房重建中的AFG是一项有前景的技术。未观察到癌症复发和并发症,安全性未受影响。AFG是否会干扰放射学随访仍有待阐明。需要采用合理方法的随机试验来证实这些结论。